ERSA AI Trademark

Trademark Overview

On Thursday, September 16, 2021, a trademark application was filed for ERSA AI with the United States Patent and Trademark Office. The USPTO has given the ERSA AI trademark a serial number of 97030825. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, September 10, 2024. This trademark is owned by Dewpoint Therapeutics, Inc.. The ERSA AI trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific condensate-based research in the field of drug discovery and drug development; providing online, non-downloadable computer software using artificial intelligence for software development, machine learning, integrated databases and workflow processes in the field of scientific research and drug discovery; online, non-downloadable computer software using artificial intelligence for software development, machine learning, integrated databases and workflow processes in the field of scientific research and drug discovery
ersa ai

General Information

Serial Number97030825
Word MarkERSA AI
Filing DateThursday, September 16, 2021
Status731 - SECOND EXTENSION - GRANTED
Status DateTuesday, September 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 18, 2023

Trademark Statements

NOT AVAILABLE"AI"
Goods and ServicesScientific condensate-based research in the field of drug discovery and drug development; providing online, non-downloadable computer software using artificial intelligence for software development, machine learning, integrated databases and workflow processes in the field of scientific research and drug discovery; online, non-downloadable computer software using artificial intelligence for software development, machine learning, integrated databases and workflow processes in the field of scientific research and drug discovery

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, December 1, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDewpoint Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameDewpoint Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events

Event DateEvent Description
Monday, September 20, 2021NEW APPLICATION ENTERED
Thursday, October 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 18, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, November 18, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 18, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 18, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 18, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 9, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 9, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 9, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 21, 2022ASSIGNED TO EXAMINER
Thursday, June 23, 2022NON-FINAL ACTION WRITTEN
Thursday, June 23, 2022NON-FINAL ACTION E-MAILED
Thursday, June 23, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 28, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 28, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 29, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 1, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 13, 2022WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, February 14, 2023PREVIOUS ALLOWANCE COUNT WITHDRAWN
Thursday, February 16, 2023NON-FINAL ACTION WRITTEN
Thursday, February 16, 2023NON-FINAL ACTION E-MAILED
Thursday, February 16, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 11, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 11, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 12, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 14, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, June 28, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 18, 2023PUBLISHED FOR OPPOSITION
Tuesday, September 12, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, March 8, 2024SOU EXTENSION 1 FILED
Friday, March 8, 2024SOU EXTENSION 1 GRANTED
Friday, March 8, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, September 10, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, September 10, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 10, 2024SOU EXTENSION 2 FILED
Tuesday, September 10, 2024SOU EXTENSION 2 GRANTED
Saturday, March 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

ersa drug software development scientific discovery field research machine processes learning